Four questions with Shivaani Kummar, MD, FACP
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could mean.
Vivek Unni, MD, PhD, is the inaugural John Hammerstad, MD, Professor of Basic Research of Movement Disorders and the interim director for the Jungers Center for Neurosciences Research. He joined the Department of Neurology and the OHSU Parkinson Center and Movement Disorders Program in 2011. Before coming to OHSU, Unni was an instructor in neurology […]
Cindy McEvoy, MD, MCR, is a physician-scientist whose research focuses on improving lung function for preterm infants — even after they leave the hospital.
Hear from OHSU Knight Cancer Institute researchers, physicians and supporters about what it looks like to end cancer as we know it.
Everyone has a story. And many stories at OHSU have been made possible by the generosity of donors.